Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Envita's AAIT - a Powerful Immunotherapy for Cancer


Published on Immunotherapy for Cancer Treatment is absolutely necessary, and many are lacking it. At Envita, it is not an afterthought but in fact, our focus. The immune system is the first and last defense against cancer, and we believe to be critical for long-term success.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Envita's AAIT - a Powerful Immunotherapy for Cancer

  1. 1. Envitas AAIT - a Powerful Immunotherapy for CancerEnvitas AAIT - a Powerful Immunotherapy for CancerAAIT is an acronym for autologous adoptive immune therapy and defines a therapy derivedfrom a patient’s own blood, which is re-infused during cancer treatment. There are abundantstrategies for immunotherapy and just as many treatments that can be referenced as“autologous adoptive immunotherapy.” Clearly, not all options are deemed comparable.Envita’s immunotherapy, AAIT, involves 4 major cell types which include Natural killercellsNatural killer T cells, Cytokine-induced killer cells, Cytotoxic T lymphocytes – where theinclusion of Natural killer cells (NKs) and Natural killer T cells (NKTs) are the predominant focusof Envita’s AAIT immunotherapy serums.Natural Killer Cells Important in Cancer Prognosis of CancerWhen NK cell numbers and functionality are low, cancer patients are predisposed to moreaggressive tumor growth. And, as disease progresses, such declines are likely to continue. Inboth animal and human clinical trials, we have seen that by restoring NK and NKT functionleads to enhanced cellular immune tumor-response and higher patient survival rates.Keys to Envitas AAIT Immunotherapy Uniqueness1) Envitas protocol for AAIT immunotherapy is designed to optimize the expansion of naturalkiller cells - the most potent cancer fighting component of the cellular immune system. Mostimmunotherapy treatments do not include natural killer cells, and those that do only expandthem in low numbers with little activation.2) Envitas AAIT immunotherapy protocol takes only 4-5 weeks to grow your cells, so you can
  2. 2. begin to experience benefits quickly. Moreover, while other immune therapies administer just100-200 million cells per treatment, Envita delivers roughly 100 times as many during thecourse of your treatment.3) Multitudes of published studies demonstrate the effects of adoptive immunotherapy forcancer patients among which Envita has identified and improved upon the best. Companyprotocol insists upon the highest-level of procedure for the expansion and application of cells foreach immunotherapy treatment.4) Unlike other published immune therapies, Envitas AAIT is the only one that can be used asa “stand-alone.” Moreover, it may also be administered in conjunction with other therapies toenhance the cells’ effects in patients – an incomparable benefit. Envitas AAIT immunotherapyis not focused solely on expanding cells in the lab; rather, our goal also includes keeping themactive until reintroduced to the patient’s body.5) Envita’s AAIT immunotherapy vaccine offers far greater tumor kill, or cytotoxicity than that ofother well-regarded cancer cell vaccines / immunotherapy treatments found throughout theworld. In brief, this means Envita’s activated natural killer cells in AAIT immunotherapy deliverconsiderably higher tumor obliteration.6) In summary, the most direct manner to stack Envita’s proprietary immunotherapy against theothers includes its: a. Quality - based on cytoxicity (how much tumor the immune system can kill). Envita’s AAIT immunotherapy consistently delivers “significantly greater tumor kill”. b. Quantity (how many cells you get back) – Envita’s AAIT immunotherapy comes with 100 times the cell dosage than the others. c. Sterility (quality control measures) – Envita AAIT immunotherapy is completely contaminant free.If you have any questions concerning Envitas AAIT immunotherapy, please consult withEnvitas team of physicians and patient educators. This immunotherapy is offered at Envita’sinternational cancer center in Mexico.